Can a diabetes drug protect blood vessels in kidney disease?
NCT ID NCT04930549
First seen Feb 06, 2026 · Last updated Apr 23, 2026 · Updated 10 times
Summary
This study tested whether taking dapagliflozin for 12 weeks improves blood vessel function in people with chronic kidney disease. 32 adults with moderate kidney disease took the drug, and researchers measured changes in artery health using ultrasound. The goal was to see if this medication could help control blood vessel damage linked to kidney disease.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RENAL INSUFFICIENCY CHRONIC are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Department of Nephrology
Bois-Guillaume, 76230, France
-
Department of Pharmacology
Rouen, 76031, France
Conditions
Explore the condition pages connected to this study.